Фармакотерапевтична група: хинолонови антибактериални, флуорохинолони, АТС код J01 МА 14.
The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair.